Phenylketonuria clinical trials at UC Health
2 in progress, 1 open to eligible people
open to all eligible people
The objective of this study is to evaluate the safety of long-term treatment with Kuvan.
at UCLA UCSD
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
Sorry, in progress, not accepting new patients
The BMN 165 clinical development program has been designed to demonstrate the safety and efficacy of BMN 165 in reducing blood Phe concentrations in adults with PKU.